ダウンロード数: 179
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
37_0039.pdf | 303.43 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | 布施, 秀樹 | ja |
dc.contributor.author | 梅田, 慶一 | ja |
dc.contributor.author | 風間, 泰蔵 | ja |
dc.contributor.author | 酒本, 護 | ja |
dc.contributor.author | 坂井, 健彦 | ja |
dc.contributor.author | 藤城, 儀幸 | ja |
dc.contributor.author | 水野, 一郎 | ja |
dc.contributor.author | 片山, 喬 | ja |
dc.contributor.alternative | Fuse, Hideki | en |
dc.contributor.alternative | Umeda, Keiichi | en |
dc.contributor.alternative | Kazama, Taizo | en |
dc.contributor.alternative | Sakamoto, Mamoru | en |
dc.contributor.alternative | Sakai, Takehiko | en |
dc.contributor.alternative | Fujishiro, Yoshiyuki | en |
dc.contributor.alternative | Mizuno, Ichiro | en |
dc.contributor.alternative | Katayama, Takashi | en |
dc.date.accessioned | 2010-06-01T02:20:49Z | - |
dc.date.available | 2010-06-01T02:20:49Z | - |
dc.date.issued | 1991-01 | - |
dc.identifier.issn | 0018-1994 | - |
dc.identifier.uri | http://hdl.handle.net/2433/117091 | - |
dc.description.abstract | 1979年1月~1990年3月までの再燃27例を対象に検討した.1)再燃は局所3例・全身8例・合併16例で, 2)再燃時腫瘍マーカー上昇の先行例11で全身例6, 3)再燃時PAP-RIA:21/27例・γ-Sm:15/18例・PAは12/15例で陽性となり, マーカー3種の陽性はほぼ同時期であった | ja |
dc.description.abstract | Twenty-seven cases of reactivated prostatic cancer between 1979 and 1990 were investigated. Reactivation took place in the form of local aggravation in 3 cases, occurrence or aggravation of metastasis to bones in 8 cases, and in both forms in 16 cases. The elevation of tumor markers preceded the clinical findings in 11 cases (41%). In 75% of the cases with occurrence or aggravation of metastasis, the elevation of tumor markers preceded the clinical findings. This showed that tumor markers were useful in most cases for early detection of reactivation. However, in 3 cases with local aggravation, the clinical findings preceded the elevation of tumor marks. Therefore, it is also important to check the clinical findings at the follow-up. At the time of reactivation, positive rates of prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostatic specific antigen (PA) were 78%, 83% and 80%, respectively. Thus gamma-Sm and PA appeared to be more reliable than PAP for monitoring of prostatic cancer. | en |
dc.format.mimetype | application/pdf | - |
dc.language.iso | jpn | - |
dc.publisher | 泌尿器科紀要刊行会 | ja |
dc.subject | Acid Phosphatase/analysis | en |
dc.subject | Antigens, Neoplasm/analysis | en |
dc.subject | Humans | en |
dc.subject | Male | en |
dc.subject | Prostate-Specific Antigen | en |
dc.subject | Prostatic Neoplasms/diagnosis/pathology | en |
dc.subject | Prostatic Secretory Proteins | en |
dc.subject | Proteins/analysis | en |
dc.subject | Seminal Plasma Proteins | en |
dc.subject | Tumor Markers, Biological/analysis | en |
dc.subject.ndc | 494.9 | - |
dc.title | 前立腺癌の再燃と腫瘍マーカー | ja |
dc.title.alternative | Relationship between reactivation and tumor markers in prostatic cancer | en |
dc.type | departmental bulletin paper | - |
dc.type.niitype | Departmental Bulletin Paper | - |
dc.identifier.ncid | AN00208315 | - |
dc.identifier.jtitle | 泌尿器科紀要 | ja |
dc.identifier.volume | 37 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 39 | - |
dc.identifier.epage | 43 | - |
dc.textversion | publisher | - |
dc.sortkey | 08 | - |
dc.address | 富山医科薬科大学医学部泌尿器科学教室 | ja |
dc.address.alternative | The Department of Urology, Faculty of Medicine, Toyama Medical and Pharmaceutical University | en |
dc.identifier.pmid | 1707217 | - |
dcterms.accessRights | open access | - |
dc.identifier.pissn | 0018-1994 | - |
dc.identifier.jtitle-alternative | Acta urologica Japonica | la |
dc.identifier.jtitle-alternative | Hinyokika Kiyo | en |
出現コレクション: | Vol.37 No.1 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。